Meredith Walker Allain, MD
Medical Genetics and Genomics · New Orleans
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 11 years
- Louisiana State University School of Medicine in New Orleans, 2015
Offices
1 location · Ochsner Clinic LLC · 2,845 clinicians in this group
Looking this up.
Hospitals listed: Ochsner Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Allain’s office at (504) 842-3900 to ask if they take your plan before you enroll.
California Medical Board record
Licence A146935 · Cancelled
Licence status: Cancelled · since 2017 · Louisiana State University School of Medicine in New Orleans.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ochsner Medical Center AcuteNew Orleans, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ochsner Health System, which runs 36 hospitals in 3 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.34 (0.89 to 1.8) · 9,200 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Abdominal Hysterectomy: 3.744, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.212, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.298, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.176, Oct 2024 – Sep 2025Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 9.9 (7.9 to 12.4) · 3,298 cases, Jan 2022 – Dec 2024
See every measure and the patient survey for Ochsner Medical Center Acute
Behind the star rating — Deaths: 2 better, 5 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 6 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.34 (0.89 to 1.8) · 9,200 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 3.744 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.212 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.176 | Better | Oct 2024 – Sep 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 9.9 (7.9 to 12.4) · 3,298 cases | Better | Jan 2022 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.86 (0.07 to 1.65) · 2,712 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.93 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.07 (136.7 to 209.45) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 596 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 419 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 8,405 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.03 to 0.39) · 10,838 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.36) · 11,193 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (1.04 to 4.27) · 3,022 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0.1 to 2.45) · 1,392 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.06 (1.92 to 4.21) · 2,824 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.85 (5.53 to 14.16) · 1,336 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (2.4 to 7.48) · 1,367 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.87 (1.55 to 4.2) · 893 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 72 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.742 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 606 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 2,168 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.2 · 192 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.2 · 724 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.3 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 1,209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (5.1 to 8.1) · 663 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (7.9 to 11.7) · 663 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.3 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 603 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,666 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,973 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$7,968 in 2024
Medicaid paid $7,968 for 291 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family | 276 | $7,170 |
| 1ST HOSP IP/OBS SF/LOW 40 | 15 | $797 |
| 2024 | 291 | 2 | 30 | $7,968 |
| 2023 | 468 | 5 | 32 | $10,039 |
| 2022 | 941 | 7 | 29 | $28,083 |
| 2021 | 334 | 4 | 26 | $12,800 |
| 2020 | 336 | 4 | 35 | $13,619 |
| 2019 | 77 | 2 | 20 | $7,639 |
| 2018 | 33 | 1 | 33 | $1,125 |
See the largest Medicaid services in earlier years
2023
| Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family | 319 | $7,492 |
| New patient visit (60+ min) | 13 | $1,778 |
| Short return visit (20+ min) | 18 | $535 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 84 | $232 |
| Medication list documented in medical record (COA) | 34 | $0 |
2022
| New patient visit (60+ min) | 162 | $17,687 |
| Short return visit (20+ min) | 112 | $4,078 |
| Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family | 277 | $3,755 |
| Long return visit (40+ min) | 18 | $1,324 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 16 | $774 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 173 | $465 |
| Medication list documented in medical record (COA) | 183 | $0 |
2021
| New patient visit (60+ min) | 82 | $9,094 |
| Short return visit (20+ min) | 66 | $2,454 |
| Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family | 97 | $1,034 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 89 | $218 |
2020
| New patient visit (60+ min) | 93 | $11,592 |
| Short return visit (20+ min) | 56 | $1,863 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 48 | $103 |
| Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family | 139 | $61 |
2019
| New patient visit (60+ min) | 60 | $7,120 |
| Short return visit (20+ min) | 17 | $519 |
2018
| Service | 33 | $1,125 |
Drugs they prescribed that Part D paid
$81,933
Pharmacies billed $81,933 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 27) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 17 brand-name prescriptions · $81,933 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 27 | None | 0% (0) | 63% | $81,933 |
| 2023 | 12 | None | 0% (0) | None | $12,632 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$66 in 2023
| 2023 | 1 | 3 | None | $66 |
| 2022 | 3 | 3 | None | $114 |
| 2021 | 2 | 2 | None | $123 |
| 2020 | 3 | 4 | None | $72 |
| 2019 | 4 | 6 | None | $202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Fabrazyme | $66 | 3 payments
|
See all 3 published payments
| Genzyme | Meals · 2023-06-08 | Fabrazyme | $17 |
| Genzyme | Meals · 2023-06-05 | Fabrazyme | $25 |
| Genzyme | Meals · 2023-05-12 | Fabrazyme | $24 |
See earlier years (2022, 2021, 2020, 2019)
2022: $114
| Amicus Therapeutics | None | $70 | 1 payment
|
| Genzyme | None | $22 | 1 payment
|
| Jazz Pharmaceuticals | Epidiolex | $22 | 1 payment
|
2021: $123
| Seagen | None | $99 | 1 payment
|
| Genzyme | Fabrazyme | $24 | 1 payment
|
2020: $72
| Genzyme | Fabrazyme | $39 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $17 | 1 payment
|
| Ucb | Briviact | $15 | 1 payment
|
2019: $202
| Genzyme | Lumizyme | $143 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $25 | 1 payment
|
| Ucb | Briviact | $20 | 1 payment
|
| Eisai | Fycompa | $15 | 1 payment
|
Professional record
- NPI
- 1912394925
- Licence
- CA A146935, LA 320358California A146935: Cancelled
- Trained
- Louisiana State University School of Medicine in New Orleans, 2015 · 11 years ago
- Group
- Ochsner Clinic LLC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207SG0201X (207SG0201X); Pediatrics (208000000X)
- Mailing address
- 1514 Jefferson Hwy, New Orleans, LA, 70121
- NPI first listed
- 2015-04-17
- NPI last updated
- 2019-09-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave Ste 210, San Jose, CA, 95128